Company Overview
Snapshot
Founded in January 2010, Clil Medical operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of an implantable artificial kidney solution.
Business overview
Clil Medical is a Health Tech & Life Sciences company developing an implantable artificial kidney solution. Its core technology utilizes bone marrow as a safe access point to the circulatory system, with excess fluid drainage shunted to the genitourinary system. The company serves the healthcare industry, specifically providers, with a focus on medical devices and medical treatment & therapeutics.
Company Intelligence Q&A
- What is Clil Medical's primary focus?
- Clil Medical is focused on developing a fully implantable artificial kidney solution designed to provide a novel treatment for kidney failure.
- What is the core technology behind Clil Medical's device?
- The device utilizes bone marrow as a safe and effective access point to the circulatory system, while drainage of excess fluid is shunted to the genitourinary system.
- What stage of development is Clil Medical currently in?
- Clil Medical is currently in the R&D product stage, with successful in-vivo and ex-vivo trials demonstrating the efficacy and proof of concept for its device.
- Which markets does Clil Medical target?
- Clil Medical targets the healthcare and life sciences markets, specifically aiming to serve healthcare providers with its medical device technology.
- What is Clil Medical's operational status?
- Clil Medical has been non-active since November 2016.